반응식
C1N=CN(C(N2C=NC=C2)=O)C=1.[C:13]([NH:20][CH2:21][C:22]([OH:24])=O)([O:15][C:16]([CH3:19])([CH3:18])[CH3:17])=[O:14].[C:25]1([CH:31]2[NH:36][CH2:35][CH2:34][N:33]3[CH:37]=[CH:38][CH:39]=[C:32]23)[CH:30]=[CH:29][CH:28]=[CH:27][CH:26]=1.[N-]1C=CN=C1.C(NCC(O)=O)(OC(C)(C)C)=O>ClCCCl>[O:24]=[C:22]([N:36]1[CH2:35][CH2:34][N:33]2[CH:37]=[CH:38][CH:39]=[C:32]2[CH:31]1[C:25]1[CH:26]=[CH:27][CH:28]=[CH:29][CH:30]=1)[CH2:21][NH:20][C:13](=[O:14])[O:15][C:16]([CH3:17])([CH3:18])[CH3:19]참가 물질
반응물 4
생성물 1
시약·촉매·용매 1
실험 절차
(1.1 g, 7.0 mmol) of CDI were added to a solution of Boc-glycine (1.2 g, 6.7 mmol) in DCE (20 ml), and stirring was carried out for 100 min at RT. (1.3 g, 6.7 mmol) of 1-phenyl-1,2,3,4-tetrahydropyrrolo[1,2-a]pyrazine (A2) were then added, and stirring was carried out for a further 2 h at RT. The mixture was then heated for 2 h at 50° C. (450 mg, 2 mmol) of Boc-glycine imidazolide were subsequently added, and the mixture was heated for 2 h under reflux. After cooling to RT, washing was carried out with, in succession, a 5% aq. sodium carbonate solution, a 5% aq. citric acid solution, water and brine. The organic phase was dried over MgSO4, filtered and concentrated in vacuo. CC (DCE) with the residue yielded 1.4 g (4.1 mmol, 61%) of tert-butyl 2-oxo-2-(1-phenyl-3,4-dihydropyrrolo[1,2-a]pyrazin-2(1H)-yl)ethylcarbamate.
후처리
- stirringstirring
- waitwas carried out for a further 2 h at RT
- additionwere subsequently added
- temperaturethe mixture was heated for 2 h
- temperatureunder reflux
- washwashing
- dry with materialThe organic phase was dried over MgSO4
- filtrationfiltered
- concentrationconcentrated in vacuo
출처 및 근거
- ORD 기록
- ord-9968b7d6be844da4914308379ccdf687
- 출처 데이터셋
- uspto-grants-2009_12
- 특허 번호
- US07625900B2
연결된 노트
불러오는 중…